🇺🇸 FDA
Patent

US 7998481

Modulation of NKG2D for treating or preventing solid organ allograft rejection

granted A61KA61K2039/505A61K39/39541

Quick answer

US patent 7998481 (Modulation of NKG2D for treating or preventing solid organ allograft rejection) held by The Regents of the University of California expires Mon Aug 11 2031 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Regents of the University of California
Grant date
Tue Aug 16 2011 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Aug 11 2031 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
26
CPC classes
A61K, A61K2039/505, A61K39/39541, A61P, A61P1/00